Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cancer Lett. 2014 Apr 10;345(2):164-73. doi: 10.1016/j.canlet.2013.08.014. Epub 2013 Aug 26.
Although it is now accepted that chronic inflammation plays an essential role in tumorigenesis, the underlying molecular mechanisms linking inflammation and cancer remain to be fully explored. Inflammatory mediators present in the tumor microenvironment, including cytokines and growth factors, as well as reactive oxygen species (ROS) and reactive nitrogen species (RNS), have been implicated in the etiology of inflammation-associated cancers. Epithelial NADPH oxidase (Nox) family proteins, which generate ROS regulated by cytokines, are upregulated during chronic inflammation and cancer. ROS serve as effector molecules participating in host defense or as chemo-attractants recruiting leukocytes to wounds, thereby influencing the inflammatory reaction in damaged tissues. ROS can alter chromosomal DNA, leading to genomic instability, and may serve as signaling molecules that affect tumor cell proliferation, survival, metabolism, angiogenesis, and metastasis. Targeting Noxs and their downstream signaling components may be a promising approach to pre-empting inflammation-related malignancies.
尽管现在已经接受慢性炎症在肿瘤发生中起着至关重要的作用,但将炎症与癌症联系起来的潜在分子机制仍有待充分探索。肿瘤微环境中存在的炎症介质,包括细胞因子和生长因子,以及活性氧(ROS)和活性氮(RNS),与炎症相关癌症的病因有关。上皮 NADPH 氧化酶(Nox)家族蛋白在慢性炎症和癌症期间被上调,这些蛋白可产生受细胞因子调节的 ROS。ROS 作为参与宿主防御的效应分子,或作为招募白细胞到伤口的趋化剂,从而影响受损组织中的炎症反应。ROS 可以改变染色体 DNA,导致基因组不稳定,并且可能作为影响肿瘤细胞增殖、存活、代谢、血管生成和转移的信号分子。靶向 Nox 和它们的下游信号成分可能是预防炎症相关恶性肿瘤的一种有前途的方法。